Clinical trial
Local Tolerability and Safety of Povidone K25 Eye Drops (Artificial Tears…
NCT00135824 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00135824 |
|---|---|
| Title | Local Tolerability and Safety of Povidone K25 Eye Drops (Artificial Tears Containing Povidone) Versus Placebo in Healthy Volunteers |
| Official title | Local Tolerability and Safety of Povidone K25 (Artificial Tears Containing Povidone) vs. Placebo in Healthy Volunteers |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | Povidone K25 eye drops (povidone) |
| Enrollment | 30 |
| Start date | Mar 1, 2004 |
| Primary completion | May 1, 2004 |
| Completion | May 1, 2004 |
| First posted | Aug 26, 2005 |
| Last update posted | Nov 17, 2011 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: